Scipher Medicine
  • Contact
  • Platform
  • Solutions
  • Company
  • Latest
  • Careers
  • Contact
  • Join Us

All articles

    All articles Press Releases Publications News Articles Media Kit
    Show all Press Releases Publications News Articles Media Kit
  • networking data 1/10/23
    Press releases
    Scipher Medicine Acquires CrossBridge and its SaaS Platform to Collect and Map Patient Molecular, Outcomes and Claims Data in Real Time
  • scipher medicine slash on purple background 11/10/22
    Press releases
    Scipher Medicine Announces Publication of Positive Results From AIMS Clinical Study
  • Human Disease 11/4/22
    Publications
    Patient outcomes improve when a molecular signature test guides treatment decision-making in rheumatoid arthritis
  • dna structure 6/1/22
    Publications
    Evaluation of physician global assessment in patients with b/tsDMARD therapy selection aligned with a molecular signature response classifier: an analysis from The Study to Accelerate Information of Molecular Signatures (AIMS) in Rheumatoid Arthritis
  • 5/24/22
    Press releases
    Galapagos In-licenses Novel Drug Targets for Inflammatory Bowel Disease Discovered by Scipher Medicine’s Spectra™ Platform
  • 4/28/22
    Press releases
    Scipher Medicine Publishes New Data Further Supporting Clinical Utility of PrismRA Blood Test
  • Pill packs 3/29/22
    Publications
    Budget Impact and Clinical Outcomes of a Molecular Signature to Inform TNFi Treatment Selection in Commercial Patients with Rheumatoid Arthritis 
  • Human Interactome Network 3/16/22
    Publications
    Network-based response module comprised of gene expression biomarkers predicts response to infliximab at treatment initiation in ulcerative colitis
  • Headshot of Chief Technology Officer Slava Akmaev 2/28/22
    Press releases
    Scipher Medicine to Participate in Truist Securities Life Sciences AI Symposium
  • scipher medicine slash on purple background 2/24/22
    Press releases
    Scipher Medicine Closes $110 Million Financing
  • John Strumbos 2/11/22
    Press releases
    Scipher Medicine to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
  • Sam Asgarian 2/1/22
    Press releases
    Scipher Medicine Announces Publication of Real-World Study Demonstrating Clinical Utility of PrismRA Blood Test
  • 1/6/22
    Press releases
    Scipher Medicine Leadership to Present at the 40th Annual J.P. Morgan Healthcare Conference
  • Developing New Drug Treatments 12/30/21
    Publications
    Clinical utility of therapy selection informed by predicted nonresponse to tumor necrosis factor-ɑ inhibitors: an analysis from the Study to Accelerate Information of Molecular Signatures (AIMS) in rheumatoid arthritis
  • Richard Blackburn 12/16/21
    Press releases
    Scipher Medicine Appoints Richard Blackburn to its Advisory Board

Posts navigation

1 2 … 8 Next
Scipher Medicine
  • Privacy Policy
  • Patient Opt-out Information
  • Notice of Privacy Practices
  • Terms of Use
  • Cookies Acknowledgement
  • Site Map
©2023 Scipher Medicine. All rights reserved.
    • Platform
    • Solutions
    • Company
    • Latest
    • Careers
    • Contact
    • Join Us